These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11225743)

  • 1. Insulin action in vascular endothelium: potential mechanisms linking insulin resistance with hypertension.
    Montagnani M; Quon MJ
    Diabetes Obes Metab; 2000 Oct; 2(5):285-92. PubMed ID: 11225743
    [No Abstract]   [Full Text] [Related]  

  • 2. Endothelial dysfunction, insulin resistance and diabetes: exploring the web of causality.
    Playford D; Watts GF
    Aust N Z J Med; 1999 Aug; 29(4):523-34. PubMed ID: 10868531
    [No Abstract]   [Full Text] [Related]  

  • 3. [Insulin as vasoactive hormone. Significance for diabetes, obesity and hypertension].
    Lind L; Berne C; Andersson PE; Lithell H
    Lakartidningen; 1997 Aug; 94(32-33):2730-2. PubMed ID: 9289582
    [No Abstract]   [Full Text] [Related]  

  • 4. [The metabolic syndrome and chronic vascular disease. Cellular mechanisms and potential candidate genes].
    Haller H; Knoblauch H; Schuster H; Luft FC
    Internist (Berl); 1996 Jul; 37(7):687-97. PubMed ID: 8766262
    [No Abstract]   [Full Text] [Related]  

  • 5. Obesity, hypertension, and insulin resistance.
    Bloomgarden ZT
    Diabetes Care; 2002 Nov; 25(11):2088-97. PubMed ID: 12401761
    [No Abstract]   [Full Text] [Related]  

  • 6. Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension.
    Jonk AM; Houben AJ; de Jongh RT; Serné EH; Schaper NC; Stehouwer CD
    Physiology (Bethesda); 2007 Aug; 22():252-60. PubMed ID: 17699878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance and systemic hypertension.
    Osei K
    Am J Cardiol; 1999 Jul; 84(1A):33J-36J. PubMed ID: 10418857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Insulin resistance and arterial hypertension].
    Weidmann P; Müller-Wieland D; de Courten M; Krone W
    Herz; 1995 Feb; 20(1):16-32. PubMed ID: 7713473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin resistance--a physiopathological condition with numerous sequelae: non-insulin-dependent diabetes mellitus (NIDDM), android obesity, essential hypertension, dyslipidemia and atherosclerosis].
    Pedersen O
    Ugeskr Laeger; 1992 May; 154(20):1411-8. PubMed ID: 1631967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolic syndrome X in women].
    Botella Llusiá J
    An R Acad Nac Med (Madr); 2000; 117(2):317-27; discussion 327-30. PubMed ID: 11209548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Obesity, diabetes and insulin resistance. Alterations of insulin signalling].
    Le Marchand-Brustel Y; Gual P; Aouadi M; Grémeaux T; Binétruy B; Bost F; Tanti JF
    J Soc Biol; 2006; 200(1):93-7. PubMed ID: 17144167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension in diabetes: the role of the vasculature.
    Stern N; Marcus Y
    Curr Hypertens Rep; 2004 Apr; 6(2):90-7. PubMed ID: 15010010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypertension and insulin resistance].
    Voiculescu A; Kutkuhn B; Rösen P; Grabensee B
    Wien Klin Wochenschr; 1997 Oct; 109(19):758-66. PubMed ID: 9441522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular function, insulin resistance and fatty acids.
    Steinberg HO; Baron AD
    Diabetologia; 2002 May; 45(5):623-34. PubMed ID: 12107742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endothelial dysfunction in diabetes mellitus and insulin resistance states: role of oxidative stress and potential therapeutic opportunities].
    Schaan BD; Silva AM; Irigoyen MC
    Arq Bras Endocrinol Metabol; 2010 Aug; 54(6):514-5. PubMed ID: 20857055
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypertension, diabetes mellitus and obesity].
    Heinzl S
    Med Monatsschr Pharm; 1990 Apr; 13(4):112-4. PubMed ID: 2184335
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin resistance, metabolic syndrome and endothelial dysfunction.
    Bigazzi R; Bianchi S
    J Nephrol; 2007; 20(1):10-4. PubMed ID: 17347967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvascular dysfunction as a link between obesity, insulin resistance and hypertension.
    Karaca Ü; Schram MT; Houben AJ; Muris DM; Stehouwer CD
    Diabetes Res Clin Pract; 2014 Mar; 103(3):382-7. PubMed ID: 24438874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metabolic syndrome and fatal quartet].
    Standl E
    Internist (Berl); 1996 Jul; 37(7):698-704. PubMed ID: 8766263
    [No Abstract]   [Full Text] [Related]  

  • 20. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.